Literature DB >> 12416395

Neuropathology of variant Creutzfeldt-Jakob disease.

James W Ironside1, Mark W Head, Linda McCardle, Richard Knight.   

Abstract

The clinical, neuropathological genetic and biochemical features of variant Creutzfeldt-Jakob disease (vCJD) are compared to the 926 other cases of suspected CJD referred to the National CJD Surveillance Unit laboratory from 1990-2001. Histological studies of the central nervous system, lymphoid tissues and other organs were accompanied by immunocytochemistry for prion protein (PrP); Western blot analysis of PrPRES was performed on frozen brain tissue. The pathology of vCJD showed relatively uniform morphological and immunocytochemical characteristics, with PrP accumulation in lymphoid tissues, but not in other non-neural tissues. PrPRES accumulation in vCJD showed a uniform glycotype pattern distinct from sporadic CJD. All cases of vCJD were methionine homozygotes at codon 129 of the PrP gene. In view of the spread of bovine spongiform encephalopathy in Europe and Japan, continuing surveillance is required for all forms of CJD, with histological and biochemical analysis of suspected cases to allow an accurate laboratory diagnosis.

Entities:  

Mesh:

Year:  2002        PMID: 12416395

Source DB:  PubMed          Journal:  Acta Neurobiol Exp (Wars)        ISSN: 0065-1400            Impact factor:   1.579


  5 in total

1.  Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties.

Authors:  Matthew T Bishop; Robert G Will; Jean C Manson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

2.  Changes of tau profiles in brains of the hamsters infected with scrapie strains 263 K or 139 A possibly associated with the alteration of phosphate kinases.

Authors:  Gui-Rong Wang; Song Shi; Chen Gao; Bao-Yun Zhang; Chan Tian; Chen-Fang Dong; Rui-Min Zhou; Xiao-Li Li; Cao Chen; Jun Han; Xiao-Ping Dong
Journal:  BMC Infect Dis       Date:  2010-04-01       Impact factor: 3.090

3.  Raised CSF phospho-tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications.

Authors:  C A Goodall; M W Head; D Everington; J W Ironside; R S G Knight; A J E Green
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

4.  Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone.

Authors:  Ignazio Cali; Cathleen J Miller; Joseph E Parisi; Michael D Geschwind; Pierluigi Gambetti; Lawrence B Schonberger
Journal:  Acta Neuropathol Commun       Date:  2015-06-25       Impact factor: 7.801

Review 5.  Prion Strains and Transmission Barrier Phenomena.

Authors:  Angélique Igel-Egalon; Vincent Béringue; Human Rezaei; Pierre Sibille
Journal:  Pathogens       Date:  2018-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.